Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)

by Hans-Henrik Parving, Barry M Brenner, John JV McMurray, Dick de Zeeuw, Steven M Haffner, Scott D Solomon, Nish Chaturvedi, Frederik Persson, Maria Nicolaides, Alexia Richard, Zhihua Xiang, Juergen Armbrecht, Marc A Pfeffer
Published 2012-09-01